Literature DB >> 24816920

Letter regarding the article of Jiao G. J. et al. entitled "Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis".

Shaozhong He1, Zhenyu Xiao, Guangxuan Zeng, Longhua Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24816920     DOI： 10.1007/s13277-014-2041-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  5 in total

1.  Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma.

Authors:  David S Dickens; Rafal Kozielski; Patrick J Leavey; Charles Timmons; Timothy P Cripe
Journal:  J Pediatr Hematol Oncol       Date:  2003-04       Impact factor: 1.289

2.  Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.

Authors:  Guangjun Jiao; Tingting Ren; Qunshan Lu; Yifeng Sun; Zhiyuan Lou; Xianbo Peng; Weimin Liang; Wei Guo
Journal:  Tumour Biol       Date:  2013-07-16

3.  Expression of molecular markers in the tumor and survival prognosis in osteosarcoma.

Authors:  I V Boulytcheva; Yu N Soloviev; N E Kushlinskii; A N Mahson
Journal:  Bull Exp Biol Med       Date:  2010-12       Impact factor: 0.804

4.  COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.

Authors:  Nidra I Rodriguez; William Keith Hoots; Nadezhda V Koshkina; Jaime A Morales-Arias; Carola A Arndt; Carrie Y Inwards; Douglas S Hawkins; Mark F Munsell; Eugenie S Kleinerman
Journal:  J Pediatr Hematol Oncol       Date:  2008-07       Impact factor: 1.289

5.  Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.

Authors:  Hiroshi Urakawa; Yoshihiro Nishida; Takahiro Naruse; Hiroatsu Nakashima; Naoki Ishiguro
Journal:  Clin Orthop Relat Res       Date:  2009-03-27       Impact factor: 4.176
  5 in total
  2 in total

1.  Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.

Authors:  Na Li; Huanhuan Li; Fan Su; Jing Li; Xiaoping Ma; Ping Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma.

Authors:  Huanhuan Li; Yuli Wang; Fan Su; Jing Li; Ping Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.